Receptos rallies on Celgene, Teva buyout rumors

|About: Celgene Corporation (CELG)|By:, SA News Editor

Receptos (RCPT +20.3%) soars after Calcalist says Celgene (CELG) and Teva (TEVA) are bidding for the company.

Bids are reportedly in the $700-800M range.